AtriCure, Inc. ATRC recently announced receipt of regulatory approval from China’s National Medical Products Administration (NMPA) for its AtriClip Left Atrial Appendage (LAA) Exclusion System.

“It maintained the parallel closure and uniform pressure necessary for effective left atrial appendage exclusion. The enhanced visualization offered by the AtriClip PRO-Mini device will ...

Trial will evaluate the safety and effectiveness of the AtriCure AtriClip® Left Atrial Appendage Exclusion System for stroke prevention in cardiac surgery patients LeAAPS is a prospective ...

AtriCure, Inc. ATRC recently announced the receipt of an expanded indication for the AtriClip in CE ... of thromboembolism for whom left atrial appendage (LAA) exclusion is warranted.

That tissue seals your left atrial appendage closed and prevents any blood clots that form from getting into your blood. Close the opening with a clip. The AtriClip seals off your LAA to prevent ...

The product is now indicated for use in patients at high risk of thromboembolism for whom left atrial appendage exclusion is warranted. The AtriClip family of devices are innovative solutions ...

"It maintained the parallel closure and uniform pressure necessary for effective left atrial appendage exclusion. The enhanced visualization offered by the AtriClip PRO-Mini device will ...

"It maintained the parallel closure and uniform pressure necessary for effective left atrial appendage exclusion. The enhanced visualization offered by the AtriClip PRO-Mini device will undoubtedly ...